Krystal Biotech buy Citigroup Inc.
Start price
27.02.24
/
50%
€152.00
Target price
27.02.25
€179.60
Performance (%)
14.14%
End price
28.02.25
€173.50
Summary
This prediction ended on 28.02.25 with a price of €173.50. The prediction had a final performance of 14.14%. Citigroup_Inc_ has a follow-up prediction for Krystal Biotech where he still thinks Krystal Biotech is a Buy. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Krystal Biotech | 0.508% | 0.508% | 25.165% |
| iShares Core DAX® | -2.117% | -7.974% | -1.733% |
| iShares Nasdaq 100 | -1.323% | -0.066% | 16.602% |
| iShares Nikkei 225® | -0.324% | -6.382% | 25.629% |
| iShares S&P 500 | -1.568% | -1.965% | 10.831% |
Comments by Citigroup_Inc_ for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) had its price target raised by analysts at Citigroup Inc. from $160.00 to $195.00. They now have a "buy" rating on the stock.
Ratings data for KRYS provided by MarketBeat
In the thread Trading Krystal Biotech
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Citigroup_Inc_ for Krystal Biotech
Stopped prediction by Citigroup_Inc_ for Krystal Biotech
Krystal Biotech
Start price
Target price
Perf. (%)
€233.70
12.01.26
12.01.26
€288.19
12.01.27
12.01.27
-6.89%
20.03.26
20.03.26
